Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053452 · ClinicalTrials.gov registry record · NA
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04053452: Clinical Trial NA study, sponsored by Duke University.
NCT04053452 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04053452, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.
Primary Outcome
Internerve CSA variability for each patient will be calculated as: maximal intranerve CSA variability/minimal intranerve CSA variability. Intranerve CSA variability for each nerve will be calculated as: maximal CSA/minimal CSA for median and ulnar nerves.
Interventions
- DIAGNOSTIC_TEST Peripheral nerve ultrasound
- DIAGNOSTIC_TEST Measurement of strength
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2024-02-05 |
| Phase | NA |
Why NCT04053452 stopped before completion
NCT04053452 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Peripheral nerve ultrasound is the first listed.
NCT04053452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04053452 about?
NCT04053452 is a clinical study titled "Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome". The purpose of this study is to determine if peripheral nerve ultrasound can be used as a supplemental tool to diagnose Guillain-Barre syndrome (GBS) in the acute setting and aid in prognostication.
What is the current status of trial NCT04053452?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2019-09-30. Estimated completion is 2024-02-05.
What interventions are being tested in trial NCT04053452?
The interventions under investigation include: Peripheral nerve ultrasound (DIAGNOSTIC_TEST), Measurement of strength (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04053452?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04053452's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI